FI771206A - - Google Patents

Info

Publication number
FI771206A
FI771206A FI771206A FI771206A FI771206A FI 771206 A FI771206 A FI 771206A FI 771206 A FI771206 A FI 771206A FI 771206 A FI771206 A FI 771206A FI 771206 A FI771206 A FI 771206A
Authority
FI
Finland
Application number
FI771206A
Inventor
Karl Credner
Guenter Brenner
Manfred Tauscher
Ljerka Jozic
Original Assignee
Wuelfing Johann A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1672076A external-priority patent/GB1530166A/en
Application filed by Wuelfing Johann A filed Critical Wuelfing Johann A
Publication of FI771206A publication Critical patent/FI771206A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI771206A 1976-04-24 1977-04-15 FI771206A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1672176 1976-04-24
GB1672076A GB1530166A (en) 1976-04-24 1976-04-24 Adenine derivatives

Publications (1)

Publication Number Publication Date
FI771206A true FI771206A (fi) 1977-10-25

Family

ID=26252198

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771206A FI771206A (fi) 1976-04-24 1977-04-15

Country Status (12)

Country Link
US (1) US4123534A (fi)
JP (1) JPS52151194A (fi)
AU (1) AU2450777A (fi)
DE (1) DE2716837A1 (fi)
DK (1) DK178677A (fi)
ES (1) ES458123A1 (fi)
FI (1) FI771206A (fi)
FR (1) FR2348926A1 (fi)
IE (1) IE44739B1 (fi)
NL (1) NL7704290A (fi)
SE (1) SE7704545L (fi)
YU (1) YU96177A (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU76148A1 (fi) * 1976-11-08 1978-07-10
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
DE3062034D1 (en) * 1979-07-25 1983-03-24 Beecham Wuelfing Gmbh & Co Kg Adenine derivatives possessing pharmacological activity
NL8700245A (nl) * 1986-02-14 1987-09-01 Sandoz Ag Purinederivaten, werkwijzen voor hun bereiding en geneesmiddelen die deze derivaten bevatten.
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412093A (en) * 1965-12-21 1968-11-19 Delmar Chem New adenine derivatives and method for their preparation

Also Published As

Publication number Publication date
JPS52151194A (en) 1977-12-15
FR2348926A1 (fr) 1977-11-18
DE2716837A1 (de) 1977-11-10
AU2450777A (en) 1978-10-26
NL7704290A (nl) 1977-10-26
SE7704545L (sv) 1977-10-25
IE44739B1 (en) 1982-03-10
US4123534A (en) 1978-10-31
YU96177A (en) 1982-08-31
DK178677A (da) 1977-10-25
ES458123A1 (es) 1978-10-16
IE44739L (en) 1977-10-24

Similar Documents

Publication Publication Date Title
CH640382GA3 (fi)
JPS5744448Y2 (fi)
FR2341744B1 (fi)
JPS5612936B2 (fi)
JPS5371021U (fi)
JPS5327290U (fi)
JPS5363269U (fi)
JPS5294018U (fi)
JPS5267578U (fi)
JPS52139631U (fi)
JPS52123204U (fi)
CS178390B1 (fi)
JPS52156783U (fi)
JPS5368490U (fi)
DD125292A1 (fi)
CH613846A5 (fi)
DD126601A1 (fi)
DD126472A1 (fi)
DD126317A1 (fi)
DD125443A1 (fi)
DD125435A1 (fi)
DD125431A2 (fi)
DD125389A1 (fi)
DD125373A1 (fi)
CH596988A5 (fi)

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: WUELFING, JOHANN A.